十大网赌正规网址下载(2024官方网站)

Reliable Quality

Affordable Innovation

Name Indication Clinical Trial Phase Study Title
HLX01
RA
Phase I/II

A Phase 1/2 Study to Evaluate the PK, PD, Safety, and Efficacy between HLX01 and Rituximab in Patients with Rheumatoid Arthritis

HLX01
RA
Phase III

A Phase III Study of Safety and Efficacy of HLX01+MTX in Patients with Moderate to Severe Active Rheumatoid Arthritis

XML 地图